The use of an adjuvant like β-glucan has been investigated as an anti-infection agent in acute infections or inflammatory conditions (Moorlag et al., 2020; Zervopoulou et al., 2024) as well as an anti-cancer treatment (Vuscan et al., 2024; Kalafati et al., 2020). The gene discussed is PPIB; the disease is infection.